Pharmaceutical Medicine

, Volume 22, Issue 1, pp 13–22

Number Needed to Detect

Nuances in the Use of a Simple and Intuitive Signal Detection Metric
Current Opinion

Abstract

Data mining algorithms are increasingly being used to support the process of signal detection and evaluation in pharmacovigilance. Published data mining exercises formulated within a screening paradigm typically calculate classical performance indicators such as sensitivity, specificity, predictive value and receiver operator characteristic curves. Extrapolating signal detection performance from these isolated data mining exercises to performance in real-world pharmacovigilance scenarios is complicated by numerous factors and some published exercises may promote an inappropriate and exclusive focus on only one aspect of performance. In this article, we discuss a variation on positive predictive value that we call the ‘number needed to detect’ that provides a simple and intuitive screening metric that might usefully supplement the usual presentations of data mining performance. We use a series of figures to demonstrate the nature and application of this metric, and selected adaptive variations. Even with simple and intuitive metrics, precisely quantifying the performance of contemporary data mining algorithms in pharmacovigilance is complicated by the complexity of the phenomena under surveillance and the manner in which the data are recorded in spontaneous reporting systems.

Copyright information

© Adis Data Information BV 2008

Authors and Affiliations

  • Manfred Hauben
    • 1
    • 2
    • 3
  • Ulrich Vogel
    • 4
  • Francois Maignen
    • 5
  1. 1.Department of Medicine, Risk Management Strategy, Pfizer Inc.New York University School of MedicineNew YorkUSA
  2. 2.Departments of Community and Preventive Medicine and PharmacologyNew York Medical CollegeValhallaUSA
  3. 3.School of Information Systems, Computing and MathematicsBrunel UniversityLondonEngland
  4. 4.Corporate Drug SafetyBoehringer Ingelheim GmbHIngelheim am RheinGermany
  5. 5.Post-Authorisation Pharmacovigilance, Safety and Efficacy Sector (Eudravigilance)European Medicines AgencyLondonEngland

Personalised recommendations